---
title: "Tacrine - Alzheimer'S Disease"
sidebar: mydoc_sidebar
permalink: db00382-mesh-d000544-1.html
toc: false 
---


Path ID: `DB00382_MESH_D000544_1`
{% include image.html url="images/db00382-mesh-d000544-1.png" file="db00382-mesh-d000544-1.png" alt="db00382-mesh-d000544-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D013619 | Tacrine | Drug |
| UniProt:P22303 | Cholinesterase | Protein |
| MESH:D000109 | Acetylcholine | ChemicalSubstance |
| GO:0098981 | Cholinergic synapse | CellularComponent |
| MESH:D000544 | Alzheimer's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tacrine | DECREASES ACTIVITY OF | Cholinesterase |
| Cholinesterase | INCREASES ABUNDANCE OF | Acetylcholine |
| Acetylcholine | LOCATED IN | Cholinergic Synapse |
| Cholinergic Synapse | MANIFESTATION OF | Alzheimer'S Disease |
|---------|-----------|---------|

Comment: Tacrine has been discontinued for the United States market.

Reference: 
  - [https://go.drugbank.com/drugs/DB00382](https://go.drugbank.com/drugs/DB00382)
